title: Postoperative cardiac tamponade after kidney transplantation:  a possible consequence of alemtuzumab-induced cytokine release syndrome.
authors: Phillip S
authors: PS
authors: Adams
authors: Ron
authors: R
authors: Shapiro
authors: Ibtesam A
authors: IA
authors: Hilmi
mesh_terms: D000074323:Alemtuzumab; D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects* / Q000627:therapeutic use; D002305:Cardiac Tamponade / Q000139:chemically induced* / Q000175:diagnosis; D016207:Cytokines / Q000378:metabolism*; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000601:surgery*; D016030:Kidney Transplantation / Q000276:immunology*; D008875:Middle Aged; D011184:Postoperative Period; D016559:Tacrolimus / Q000627:therapeutic use; D016896:Treatment Outcome; D028761:Withholding Treatment
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D016207:Cytokines; D007166:Immunosuppressive Agents; D000074323:Alemtuzumab; D016559:Tacrolimus